Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Whitaker

Showing results (131-140 of 215) with videos related to

Pageof 22
Sort By:
Biochemical Pharmacology|April 15, 1985
Hormonal and drug effects on the degradation of human myelin basic protein peptide 43-88 by alkaline proteolytic activity in the rat kidneyR L Trestman, M A Heinemann, J N Whitaker, et al.
Arquivos De Neuro-Psiquiatria|June 1, 1985
[Myelin basic protein in cerebrospinal fluid in neurocysticercosis]J A Livramento, L R Machado, J N Whitaker, et al.
The Journal of Cell Biology|January 1, 1980
Immunocytochemical localization of calmodulin and a heat-labile calmodulin-binding protein (CaM-BP80) in basal ganglia of mouse brainJ G Wood, R W Wallace, J N Whitaker, et al.
Annals of the New York Academy of Sciences|January 1, 1980
Immunocytochemical localization of calmodulin in regions of rodent brainJ G Wood, R W Wallace, J N Whitaker, et al.
Biochemistry|May 13, 1999
Rapid release and unusual stability of immunodominant peptide 45-89 from citrullinated myelin basic proteinL Cao, R Goodin, D Wood, et al.
Journal of Neuroscience Research|January 1, 1980
Effect of peptides of bovine myelin basic protein on dermal fibroblastsT M Chiang, J N Whitaker, J M Seyer, et al.
Journal of Neuropathology and Experimental Neurology|January 1, 1971
Fine structural aspects of demyelination in vitroH S Cook, J N Whitaker, P C Dowling, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1980
Antigenic features of myelin basic protein-like material in cerebrospinal fluidJ N Whitaker, R M Bashir, C H Chou, et al.
Neurology|December 1, 1974
Letter: Tissue nonspecificity of antinuclear antibodies in myasthenia gravisJ N Whitaker, W K Engel, S E Kornguth, et al.
Neurology|June 14, 2000
Practice parameter: the role of corticosteroids in the management of acute monosymptomatic optic neuritis [RETIRED]. Report of the Quality Standards Subcommittee of the American Academy of NeurologyD I Kaufman, J D Trobe, E R Eggenberger, et al.
Pageof 22

Showing results (131-140 of 215) with videos related to

Sort By:
Pageof 22
Biochemical Pharmacology|April 15, 1985
Hormonal and drug effects on the degradation of human myelin basic protein peptide 43-88 by alkaline proteolytic activity in the rat kidneyR L Trestman, M A Heinemann, J N Whitaker, et al.
Arquivos De Neuro-Psiquiatria|June 1, 1985
[Myelin basic protein in cerebrospinal fluid in neurocysticercosis]J A Livramento, L R Machado, J N Whitaker, et al.
The Journal of Cell Biology|January 1, 1980
Immunocytochemical localization of calmodulin and a heat-labile calmodulin-binding protein (CaM-BP80) in basal ganglia of mouse brainJ G Wood, R W Wallace, J N Whitaker, et al.
Annals of the New York Academy of Sciences|January 1, 1980
Immunocytochemical localization of calmodulin in regions of rodent brainJ G Wood, R W Wallace, J N Whitaker, et al.
Biochemistry|May 13, 1999
Rapid release and unusual stability of immunodominant peptide 45-89 from citrullinated myelin basic proteinL Cao, R Goodin, D Wood, et al.
Journal of Neuroscience Research|January 1, 1980
Effect of peptides of bovine myelin basic protein on dermal fibroblastsT M Chiang, J N Whitaker, J M Seyer, et al.
Journal of Neuropathology and Experimental Neurology|January 1, 1971
Fine structural aspects of demyelination in vitroH S Cook, J N Whitaker, P C Dowling, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1980
Antigenic features of myelin basic protein-like material in cerebrospinal fluidJ N Whitaker, R M Bashir, C H Chou, et al.
Neurology|December 1, 1974
Letter: Tissue nonspecificity of antinuclear antibodies in myasthenia gravisJ N Whitaker, W K Engel, S E Kornguth, et al.
Neurology|June 14, 2000
Practice parameter: the role of corticosteroids in the management of acute monosymptomatic optic neuritis [RETIRED]. Report of the Quality Standards Subcommittee of the American Academy of NeurologyD I Kaufman, J D Trobe, E R Eggenberger, et al.
Pageof 22